173
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Genotype-phenotype analysis of ocular findings in Rubinstein-Taybi syndrome – A case report and review of literature

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 51-58 | Received 30 Dec 2022, Accepted 23 Mar 2023, Published online: 05 Apr 2023

References

  • Rubinstein JH, Taybi H. Broad thumbs and toes and facial abnormalities: a possible mental retardation syndrome. Am J Dis Child. 1963 Jun 1;105(6):588–608. doi:10.1001/archpedi.1963.02080040590010.
  • Park E, Kim Y, Ryu H, Kowall NW, Lee J, Ryu H. Epigenetic mechanisms of Rubinstein–Taybi syndrome. Neuromolecular Med. 2014;16(1):16–24. doi:10.1007/s12017-013-8285-3.
  • Beets L, Rodríguez-Fonseca C, Hennekam RC. Growth charts for individuals with Rubinstein–Taybi syndrome. Am J Med Genet A. 2014;164(9):2300–9. doi:10.1002/ajmg.a.36654.
  • Van Gils J, Magdinier F, Fergelot P, Lacombe D. Rubinstein-Taybi syndrome: a model of epigenetic disorder. Genes. 2021 Jun 24;12(7):968. doi:10.3390/genes12070968.
  • Hennekam RCM. Rubinstein–taybi syndrome. Eur J Hum Genet. 2006 Sep;14(9):981–5. doi:10.1038/sj.ejhg.5201594.
  • Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJB, Breuning MH, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005 Apr 1;76(4):572–80. doi:10.1086/429130.
  • Lopez-Atalaya JP, Valor LM, Barco A. Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin. Prog Mol Biol Transl Sci. 2014;128:139–76.
  • Petrif F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen GJB, Goodman RH, Peters DJM, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995 Jul;376(6538):348–51. doi:10.1038/376348a0.
  • Roelfsema JH, Peters DJM. Rubinstein–taybi syndrome: clinical and molecular overview. Expert Rev Mol Med. 2007 Aug;9(23):1–16. doi:10.1017/S1462399407000415.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015 May 1;17(5):405–24. doi:10.1038/gim.2015.30.
  • Schorry EK, Keddache M, Lanphear N, Rubinstein JH, Srodulski S, Fletcher D, Blough-Pfau RI, Grabowski GA. Genotype–phenotype correlations in Rubinstein–Taybi syndrome. Am J Med Genet A. 2008;146A(19):2512–9. doi:10.1002/ajmg.a.32424.
  • Pérez-Grijalba V, García-Oguiza A, López M, Armstrong J, García-Miñaur S, Mesa-Latorre JM, O’Callaghan M, Pineda Marfa M, Ramos‐arroyo MA, Santos‐simarro F, et al. New insights into genetic variant spectrum and genotype–phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP- positive patients. Mol Genet Genomic Med. 2019 Nov;7(11):e972. doi:10.1002/mgg3.972.
  • Yu PT, Luk HM, Lo IFM. Rubinstein-Taybi syndrome in Chinese population with four novel mutations. Am J Med Genet A. 2021;185(1):267–73. doi:10.1002/ajmg.a.61922.
  • Enomoto Y, Yokoi T, Tsurusaki Y, Murakami H, Tominaga M, Minatogawa M, Abe‐hatano C, Kuroda Y, Ohashi I, Ida K, et al. Divergent variant patterns among 19 patients with Rubinstein‐Taybi syndrome uncovered by comprehensive genetic analysis including whole genome sequencing. Clin Genet. 2022;101(3):335–45. doi:10.1111/cge.14103.
  • Angius A, Uva P, Oppo M, Persico I, Onano S, Olla S, Pes V, Perria C, Cuccuru G, Atzeni R, et al. Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP. Am J Med Genet A. 2019;179(4):634–8. doi:10.1002/ajmg.a.61052.
  • Kamenarova K, Simeonov E, Tzveova R, Dacheva D, Penkov M, Kremensky I, Perenovska P, Mitev V, Kaneva R. Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report. Hum Pathol. 2016 Jan 1;47(1):144–9. doi:10.1016/j.humpath.2015.09.004.
  • Huang FR, Zhang AM, Xu J, Huang L. A clinical characteristics and genetic analysis of a case of Rubinstein-Taybi syndrome with glaucoma [Internet]. Eur Rev. 2021 [accessed 2022 May 5]. https://www.europeanreview.org/article/24852.
  • Choi N, Kim HY, Lim BC, Chae JH, Kim SY, Ko JM. Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome. Mol Genet Genomic Med. 2021 Oct;9(10):e1791. doi:10.1002/mgg3.1791.
  • Wang Q, Wang C, Wei WB, Rong WN, Shi XY. A novel CREBBP mutation and its phenotype in a case of Rubinstein–Taybi syndrome. BMC Med Genomics. 2022 Dec;15(1):1–8. doi:10.1186/s12920-022-01335-4.
  • Rusconi D, Negri G, Colapietro P, Picinelli C, Milani D, Spena S, Magnani C, Silengo MC, Sorasio L, Curtisova V, et al. Characterization of 14 novel deletions underlying Rubinstein–Taybi syndrome: an update of the CREBBP deletion repertoire. Hum Genet. 2015 Jun 1;134(6):613–26. doi:10.1007/s00439-015-1542-9.
  • Hennekam RC, Tilanus M, Hamel BC, Voshart-van Heeren H, Mariman EC, van Beersum SE, van den Boogaard MJ, Breuning MH. Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects. Am J Hum Genet. 1993 Feb;52(2):255–62.
  • Blough RI, Petrij F, Dauwerse JG, Milatovich-Cherry A, Weiss L, Saal HM, Rubinstein JH. Variation in microdeletions of the cyclic AMP-responsive element-binding protein gene at chromosome band 16p13.3 in the Rubinstein-Taybi syndrome. Am J Med Genet. 2000;90(1):29–34. doi:10.1002/(SICI)1096-8628(20000103)90:1<29:AID-AJMG6>3.0.CO;2-Z.
  • Naik JM, Naik MN, Ali MJ. Lacrimal drainage anomalies in Rubinstein-Taybi syndrome: case report and review of literature. Orbit. 2019 Aug;38(4):335–7. doi:10.1080/01676830.2018.1515961.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.